• Compromised immune systems induced by cancer treatments may make patient more susceptible to COVID-19
• Cancer treatments may require healthcare facility/inpatient stay exposing patient to asymptomatic carriers (i.e., HCW)
• Delaying of potential critical, life-prolonging surgery as it may be deemed as “elective”
• Ensuring COVID-19 testing adequacy by healthcare providers